PortfoliosLab logoPortfoliosLab logo
TRV vs. MRK
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

TRV vs. MRK - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in The Travelers Companies, Inc. (TRV) and Merck & Co., Inc. (MRK). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, TRV achieves a 30.07% return, which is significantly higher than MRK's 25.51% return. Over the past 10 years, TRV has outperformed MRK with an annualized return of 14.78%, while MRK has yielded a comparatively lower 12.26% annualized return.


TRV

1D
-0.43%
1M
9.36%
6M
32.61%
YTD
30.07%
1Y
47.23%
3Y*
31.86%
5Y*
22.60%
10Y*
14.78%
ALL TIME*
11.85%

MRK

1D
0.32%
1M
0.49%
6M
19.80%
YTD
25.51%
1Y
69.70%
3Y*
10.70%
5Y*
14.64%
10Y*
12.26%
ALL TIME*
12.54%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$997.19M$1.08B$1.21B
$902.70M$763.57M$614.43M

TRV vs. MRK - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
TRV
The Travelers Companies, Inc.
30.07%22.38%28.76%3.93%22.42%13.96%5.31%17.00%-9.64%13.36%
MRK
Merck & Co., Inc.
25.51%9.79%-6.26%1.01%49.42%1.75%-7.20%22.27%39.95%-1.49%

Correlation

The correlation between TRV and MRK is 0.30, which is low. Their historical price movements had little consistent relationship.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.30

Correlation (3Y)
Balances recent behavior with more history.

0.26

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.29

Correlation (10Y)
Provides a long-term view across more market conditions.

0.31

Correlation (All Time)
Calculated using the full available price history since Apr 22, 1996

0.32

Fundamentals

Market Cap

TRV:

$78.08B

MRK:

$321.62B

EPS

TRV:

$37.59

MRK:

$3.59

PE Ratio

TRV:

9.96

MRK:

36.23

PEG Ratio

TRV:

0.46

MRK:

0.03

PS Ratio

TRV:

1.69

MRK:

4.93

PB Ratio

TRV:

2.41

MRK:

7.02

Total Revenue (TTM)

TRV:

$48.98B

MRK:

$65.59B

Gross Profit (TTM)

TRV:

$17.01B

MRK:

$49.79B

EBITDA (TTM)

TRV:

$11.31B

MRK:

$22.69B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

TRV vs. MRK — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

TRV
TRV Risk / Return Rank: 9494
Overall Rank
TRV Sharpe Ratio Rank: 9494
Sharpe Ratio Rank
TRV Sortino Ratio Rank: 9494
Sortino Ratio Rank
TRV Omega Ratio Rank: 9393
Omega Ratio Rank
TRV Calmar Ratio Rank: 9696
Calmar Ratio Rank
TRV Martin Ratio Rank: 9595
Martin Ratio Rank

MRK
MRK Risk / Return Rank: 9696
Overall Rank
MRK Sharpe Ratio Rank: 9696
Sharpe Ratio Rank
MRK Sortino Ratio Rank: 9696
Sortino Ratio Rank
MRK Omega Ratio Rank: 9494
Omega Ratio Rank
MRK Calmar Ratio Rank: 9797
Calmar Ratio Rank
MRK Martin Ratio Rank: 9696
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

TRV vs. MRK - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for The Travelers Companies, Inc. (TRV) and Merck & Co., Inc. (MRK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


TRVMRKDifference
Sharpe ratioReturn per unit of total volatility

-0.40

Sortino ratioReturn per unit of downside risk

-0.42

Omega ratioGain probability vs. loss probability

1.41

1.44

-0.03

Calmar ratioReturn relative to maximum drawdown

5.58

6.39

-0.81

Martin ratioReturn relative to average drawdown

14.16

16.11

-1.95

TRV vs. MRK - Sharpe Ratio Comparison

The current TRV Sharpe Ratio is 2.24, which is comparable to the MRK Sharpe Ratio of 2.64. The chart below compares the historical Sharpe Ratios of TRV and MRK, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

TRV vs. MRK - Drawdown Comparison

The maximum TRV drawdown since its inception was -55.11%, smaller than the maximum MRK drawdown of -68.61%. Use the drawdown chart below to compare losses from any high point for TRV and MRK.


Loading charts...

Drawdown Indicators


TRVMRKDifference

Max Drawdown

Largest peak-to-trough decline

-55.11%

-68.61%

+13.50%

Max Drawdown (1Y)

Largest decline over 1 year

-8.31%

-11.37%

+3.06%

Max Drawdown (3Y)

Largest decline over 3 years

-12.47%

-43.44%

+30.97%

Max Drawdown (5Y)

Largest decline over 5 years

-18.90%

-43.44%

+24.54%

Max Drawdown (10Y)

Largest decline over 10 years

-46.28%

-43.44%

-2.84%

Current Drawdown

Current decline from peak

-5.75%

-1.23%

-4.52%

Average Drawdown

Average peak-to-trough decline

-11.07%

-18.79%

+7.72%

Ulcer Index

Depth and duration of drawdowns from previous peaks

3.27%

4.50%

-1.23%

Volatility

TRV vs. MRK - Volatility Comparison

The Travelers Companies, Inc. (TRV) has a higher volatility of 11.55% compared to Merck & Co., Inc. (MRK) at 8.23%. This indicates that TRV's price experiences larger fluctuations and is considered to be riskier than MRK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


TRVMRKDifference

Volatility (1M)

Calculated over the trailing 1-month period

11.55%

8.23%

+3.32%

Volatility (6M)

Calculated over the trailing 6-month period

16.55%

19.68%

-3.13%

Volatility (1Y)

Calculated over the trailing 1-year period

20.71%

27.87%

-7.16%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

22.24%

24.10%

-1.86%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

24.65%

23.13%

+1.52%

Dividends

TRV vs. MRK - Dividend Comparison

TRV's dividend yield for the trailing twelve months is around 1.22%, less than MRK's 2.58% yield.


PositionTTM20252024202320222021202020192018201720162015
MRK
Merck & Co., Inc.
2.58%3.12%3.14%2.72%2.52%3.41%3.03%2.48%2.60%3.36%3.14%3.43%
TRV
The Travelers Companies, Inc.
1.22%1.50%1.72%2.06%1.96%2.23%2.40%2.36%2.53%2.09%2.14%2.11%

Financials

TRV vs. MRK - Financials Comparison

This section allows you to compare key financial metrics between The Travelers Companies, Inc. and Merck & Co., Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

TRV vs. MRK - Profitability Comparison

The chart below illustrates the profitability comparison between The Travelers Companies, Inc. and Merck & Co., Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

TRV - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, The Travelers Companies, Inc. reported a gross profit of 4.45B and revenue of 12.15B. Therefore, the gross margin over that period was 36.6%.

MRK - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Merck & Co., Inc. reported a gross profit of 13.34B and revenue of 16.29B. Therefore, the gross margin over that period was 81.9%.

TRV - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, The Travelers Companies, Inc. reported an operating income of 2.88B and revenue of 12.15B, resulting in an operating margin of 23.7%.

MRK - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Merck & Co., Inc. reported an operating income of -1.88B and revenue of 16.29B, resulting in an operating margin of -11.6%.

TRV - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, The Travelers Companies, Inc. reported a net income of 2.21B and revenue of 12.15B, resulting in a net margin of 18.2%.

MRK - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Merck & Co., Inc. reported a net income of -4.24B and revenue of 16.29B, resulting in a net margin of -26.0%.


Frequently Asked Questions


TRV and MRK have a correlation of 0.30, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

TRV has higher volatility (11.55%) compared to MRK (8.23%). In terms of maximum drawdown, TRV dropped -55.11% vs MRK's -68.61%.

MRK currently has the higher Sharpe Ratio (2.64 vs 2.24), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for TRV and MRK

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer